These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 1099576

  • 21. [Clinical experience with betain citrate (author's transl)].
    Babucke G, Sarre B.
    Med Klin; 1973 Aug 24; 68(34):1109-13. PubMed ID: 4364431
    [No Abstract] [Full Text] [Related]

  • 22. [A two-center study on the effects of silymarin in pregnant women and adult patients with so-called minor hepatic insufficiency].
    Giannola C, Buogo F, Forestiere G, Scaffidi L, Ferrigno V, Scaffidi A.
    Clin Ter; 1985 Jul 31; 114(2):129-35. PubMed ID: 4053531
    [No Abstract] [Full Text] [Related]

  • 23. [Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial (author's transl)].
    Bode JC, Schmidt U, Dürr HK.
    Med Klin; 1977 Mar 25; 72(12):513-8. PubMed ID: 840125
    [Abstract] [Full Text] [Related]

  • 24. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases].
    Deák G, Müzes G, Láng I, Niederland V, Nékám K, Gonzalez-Cabello R, Gergely P, Fehér J.
    Orv Hetil; 1990 Jun 17; 131(24):1291-2, 1295-6. PubMed ID: 2195425
    [Abstract] [Full Text] [Related]

  • 25. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].
    Mazzanti R, Arcangeli A, Salvadori G, Smorlesi C, Di Perri T, Auteri A, Boggiano CA, Pippi L, Toti M, Boncompagni P, Angioli D, Caremani M, Magnolfi F, Camarri E, Motta R, Forconi A, Candidi Tommasi A, Lomi M, Soldi A.
    Minerva Med; 1978 Oct 13; 69(48):3283-92. PubMed ID: 724140
    [No Abstract] [Full Text] [Related]

  • 26. Cytoprotection in the nineties: experience with ursodeoxycholic acid and silymarin in chronic liver disease.
    Lirussi F, Okolicsanyi L.
    Acta Physiol Hung; 1992 Oct 13; 80(1-4):363-7. PubMed ID: 1345202
    [Abstract] [Full Text] [Related]

  • 27. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R, Weber D.
    Ther Ggw; 1972 Mar 13; 111(3):400-12. PubMed ID: 5024593
    [No Abstract] [Full Text] [Related]

  • 28. [A contribution to the treatment of chronic liver diseases (author's transl)].
    Möller E, Schmitt R.
    Med Klin; 1976 Oct 22; 71(43):1831-5. PubMed ID: 825708
    [Abstract] [Full Text] [Related]

  • 29. [Glucocorticoids in chronic liver diseases].
    Maier KP, Talke H, Gerok W.
    Dtsch Med Wochenschr; 1975 Mar 14; 100(11):560-3. PubMed ID: 1116441
    [No Abstract] [Full Text] [Related]

  • 30. [Therapeutic effect of silymarin in patients with liver cirrhosis].
    Kupcová V, Turecký L, Holomán J, Ulicná O, Brixová E, Volmut J.
    Cas Lek Cesk; 1987 Nov 06; 126(45):1406-9. PubMed ID: 3427593
    [No Abstract] [Full Text] [Related]

  • 31. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
    Rapino P, Marulli R, Rapex G, Della Lunga S, Sabatino P.
    Minerva Med; 1982 Oct 20; 73(40):2853-60. PubMed ID: 7133498
    [No Abstract] [Full Text] [Related]

  • 32. [Pharmaco-metabolic activity in chronic hepatopathies: influence of treatment with UDPG].
    Okolicsànyi L, Orlando R, Lirussi F, Naccarato R, Dal Brun G.
    Clin Ter; 1980 May 31; 93(4):431-8. PubMed ID: 6998643
    [No Abstract] [Full Text] [Related]

  • 33. [Long-term therapy of liver diseases].
    Markoff N.
    Wien Med Wochenschr; 1972 Feb 12; 122(7):95-9. PubMed ID: 4621921
    [No Abstract] [Full Text] [Related]

  • 34. [Immunosuppressive drugs in the treatment of liver diseases (author's transl)].
    Magnenat P.
    Ther Umsch; 1979 May 12; 36(5):432-8. PubMed ID: 451956
    [No Abstract] [Full Text] [Related]

  • 35. [Observations on the treatment of chronic inflammatory liver diseases with the preparation Hepasteril B comp].
    Busse K, Otremba P.
    Soins; 1970 May 12; 15(7):2608-13. PubMed ID: 4918343
    [No Abstract] [Full Text] [Related]

  • 36. [Clinical experimentation with Aïcamine in hepatic insufficiency].
    Négret JP.
    Bord Med; 1972 Apr 12; 5(8):973-6. PubMed ID: 5053280
    [No Abstract] [Full Text] [Related]

  • 37. [Sylimarol in the treatment of acute viral hepatitis].
    Tkacz B, Dworniak D.
    Wiad Lek; 1983 Apr 15; 36(8):613-6. PubMed ID: 6353775
    [No Abstract] [Full Text] [Related]

  • 38. [Experience in the treatment of chronic hepatopathies with silymarin].
    Poser G.
    Arzneimittelforschung; 1971 Aug 15; 21(8):1209-12. PubMed ID: 5110021
    [No Abstract] [Full Text] [Related]

  • 39. [Use of a titrated extract of Centella asiatica in chronic hepatic disorders (author's transl)].
    Darnis F, Orcel L, de Saint-Maur PP, Mamou P.
    Sem Hop; 1971 Aug 15; 55(37-38):1749-50. PubMed ID: 230597
    [Abstract] [Full Text] [Related]

  • 40. [Clinical experience report on Hepavis].
    Menninger U, Menninger W.
    Med Welt; 1980 Oct 17; 31(42):1519-21. PubMed ID: 7453534
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.